For Linux server and infrastructure operators, we have organized the vulnerabilities newly reported in the past 24 hours (JST ...
The AI-driven biotech has secured FDA alignment on a pivotal trial for its FAP therapy, with a study start planned for 2027.
REC-4881 is among the first AI-enabled programs to advance a registrational Phase 3 trial design for a disease with no approved pharmacologic therapies. Its potential as a first-in-class oral therapy ...
A critical vulnerability dubbed Java4Shell in OpenJDK, the open-source implementation of Java, can allow unauthenticated ...
Transformer on MSNOpinion

Policy can still work on short timelines

Transformer Weekly: California makes a bid to regulate AI, a new FRONTIER ACT, and Anthropic’s record-breaking IPO ...
Recursion Pharmaceuticals said on November 18, 2026 that it had aligned with the U.S. Food and Drug Administration on a ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
RXRX is trading in the middle of its 52-week range and below its 200-day simple moving average. Price change The price of RXRX shares has decreased $0.10 since the market last closed. This is a 3.72% ...
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
In the field of artificial intelligence, machine learning is a branch that uses data and algorithms to imitate human learning. It's an ongoing process in which computers can improve their accuracy ...
NVIDIA launches RTX Spark Compact Desktops with Acer and ASUS, featuring the N1X Superchip and 128GB Unified Memory for local ...